Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori
Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in...
Saved in:
Published in | The American journal of clinical nutrition Vol. 80; no. 3; pp. 737 - 741 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
American Society for Clinical Nutrition
01.09.2004
American Society for Clinical Nutrition, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans. |
---|---|
AbstractList | Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans.BACKGROUNDEvidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans.We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth.OBJECTIVEWe administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth.The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the (13)C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation.DESIGNThe in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the (13)C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation.Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001).RESULTSBb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001).Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans.CONCLUSIONRegular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans. Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (107 colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans. [PUBLICATION ABSTRACT] Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. Objective: We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. Design: The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the 13C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Results: Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Conclusion: Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans. Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing with Lactobacillus- and Bifidobacterium-containing yogurt (AB-yogurt) was shown to improve the rates of eradication of H. pylori in humans. We administered AB-yogurt to subjects with asymptomatic H. pylori to test whether the yogurt could inhibit H. pylori growth. The in vitro inhibition of H. pylori growth was determined by inoculating Lactobacillus acidophilus La5 or Bifidobacterium lactis Bb12 on plates that were inoculated with H. pylori. Assessment of the viability of H. pylori was performed by the mixed culture method with La5 or Bb12. In an intervention study, 59 adult volunteers infected with H. pylori were given AB-yogurt (10(7) colony-forming units of both La5 and Bb12/mL) twice daily after a meal for 6 wk. Eleven subjects positive for H. pylori infection were treated with milk placebo as control subjects. H. pylori bacterial loads were determined with use of the (13)C-urea breath test, which was performed before and 4 and 8 wk after the start of AB-yogurt supplementation. Bb12 exerted an in vitro inhibitory effect against H. pylori, whereas La5 did not show an effect. Administration of AB-yogurt decreased the urease activity of H. pylori after 6 wk of therapy (P < 0.0001). Regular intake of yogurt containing Bb12 and La5 effectively suppressed H. pylori infection in humans. |
Author | Li, S.N Su, Y.C Jan, C.M Liu, C.S Wu, D.C Perng, D.S Lai, C.H Wang, T.N Wang, K.Y Wang, W.M |
Author_xml | – sequence: 1 fullname: Wang, K.Y – sequence: 2 fullname: Li, S.N – sequence: 3 fullname: Liu, C.S – sequence: 4 fullname: Perng, D.S – sequence: 5 fullname: Su, Y.C – sequence: 6 fullname: Wu, D.C – sequence: 7 fullname: Jan, C.M – sequence: 8 fullname: Lai, C.H – sequence: 9 fullname: Wang, T.N – sequence: 10 fullname: Wang, W.M |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16071354$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15321816$$D View this record in MEDLINE/PubMed |
BookMark | eNqF0M-PEyEUB3Bi1rjd1aNXJSZ6m-4DBgaOutkfJk086J4nQKHSUKgwE61_vdStMfHiBQj5vAfve4HOUk4OoZcElgQUu9Jbm64kLNlyYMMTtCCKyY5RGM7QAgBop4jg5-ii1i0Aob0Uz9A54YwSScQC_bjx3tmp4uxxSBtXp7bilbZTNtqGGOfaYZ3W-EPwYX28m1wJ866zOU06pKM-5M1cplaO62y2v7t9D9NXbHPMKfx0a3zvYrCnYrw_xFzCc_TU61jdi9N-iR5ub75c33erT3cfr9-vOs-ImrqecSE4l2DaiQsnDQVKiRh6Kwk4bqQxnhgFjilqqDTKMM-Mt0QLA3xgl-jdY999yd_mNt-4C9W6GHVyea6jEBJaHPy_sFfHaKFv8M0_cJvnktoQI21_ZkoJ2tCrE5rNzq3HfQk7XQ7jn-QbeHsCulodfdHJhvrXCRgI48fXXj86r_OoN6WZh88UCANQ_dAiYb8AB5edqA |
CODEN | AJCNAC |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS Copyright American Society for Clinical Nutrition, Inc. Sep 2004 |
Copyright_xml | – notice: 2004 INIST-CNRS – notice: Copyright American Society for Clinical Nutrition, Inc. Sep 2004 |
DBID | FBQ IQODW CGR CUY CVF ECM EIF NPM 7QP 7T7 7TS 8FD C1K FR3 K9. NAPCQ P64 7S9 L.6 7X8 |
DOI | 10.1093/ajcn/80.3.737 |
DatabaseName | AGRIS Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Physical Education Index Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Calcium & Calcified Tissue Abstracts Physical Education Index Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Nursing & Allied Health Premium MEDLINE AGRICOLA |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Diet & Clinical Nutrition |
EISSN | 1938-3207 |
EndPage | 741 |
ExternalDocumentID | 713206731 15321816 16071354 US201300947556 |
Genre | Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -ET -~X ..I .55 .GJ 0R~ 1HT 23M 2FS 2WC 3O- 4.4 48X 53G 5GY 5RE 5VS 6J9 85S 8R4 8R5 AABZA AACZT AAGQS AAHBH AAIKC AAJQQ AAMNW AAPGJ AAPQZ AAUQX AAUTI AAVAP AAWDT AAWTL AAXUO AAYOK ABBTP ABDNZ ABDPE ABIME ABJNI ABLJU ABOCM ABPTD ABWST ACFRR ACGFO ACGFS ACGOD ACNCT ACPRK ACPVT ACUFI ACUTJ ADBBV ADGZP ADHUB ADMTO ADRTK ADUKH ADVEK ADVLN AEGXH AENEX AETBJ AFFDN AFFNX AFFZL AFJKZ AFOFC AFRAH AFXAL AGINJ AGKRT AGNAY AGQXC AGUTN AHMBA AI. AIAGR AITUG AJEEA AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANFBD AQDSO AQKUS BAWUL BAYMD BKOMP BTRTY C1A CDBKE DAKXR DIK E3Z EBS EIHJH EJD ENERS EX3 F5P F9R FBQ FDB FECEO FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 HF~ HZ~ IH2 J5H KBUDW KOP KQ8 KSI KSN L7B LPU MBLQV MHKGH MV1 MVM N4W NEJ NHB NHCRO NOMLY NOYVH NVLIB O9- ODMLO OHT OK1 OVD P2P P6G PCD PQQKQ PRG Q2X R0Z RHI RNS ROL SJN TCN TEORI TMA TNT TR2 TWZ UBH UHB UKR VH1 W2D W8F WH7 WHG WOQ WOW X7M XOL XSW YBU YHG YOJ YQJ YR5 YRY YSK YV5 YYQ YZZ ZCA ZCG ZGI ZUP ZXP ~KM AALRI AAYWO ACVFH ADCNI AEUPX AFPUW AGCQF AIGII AKBMS AKYEP APXCP EFKBS IQODW NU- A8Z ABSAR BCRHZ CGR CUY CVF ECM EIF NPM RHF ROX SV3 VXZ Z5M 7QP 7T7 7TS 8FD C1K FR3 K9. NAPCQ P64 7S9 L.6 7X8 |
ID | FETCH-LOGICAL-f319t-435665580b43556e8b20221674c810e5b8bbf1b90e392b28b9b3f3bfc1a6b0573 |
ISSN | 0002-9165 |
IngestDate | Thu Jul 10 23:49:37 EDT 2025 Mon Jul 21 09:44:18 EDT 2025 Fri Jul 25 05:04:13 EDT 2025 Wed Feb 19 02:24:36 EST 2025 Mon Jul 21 09:16:20 EDT 2025 Thu Apr 03 09:46:48 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Probiotic Bifidobacterium Actinomycetaceae Spirillales Lactobacillus acidophilus La5 Spirillaceae Yogurt Lactobacillus acidophilus Actinomycetales Urea Probiotics Breath test Helicobacter pylori Bifidobacterium lactis Bb12 Bacteria Lactobacillaceae Actinomycetes urea breath test |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-f319t-435665580b43556e8b20221674c810e5b8bbf1b90e392b28b9b3f3bfc1a6b0573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 ObjectType-Undefined-3 |
PMID | 15321816 |
PQID | 231939962 |
PQPubID | 41076 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_66801535 proquest_miscellaneous_49193804 proquest_journals_231939962 pubmed_primary_15321816 pascalfrancis_primary_16071354 fao_agris_US201300947556 |
PublicationCentury | 2000 |
PublicationDate | 2004-09-01 |
PublicationDateYYYYMMDD | 2004-09-01 |
PublicationDate_xml | – month: 09 year: 2004 text: 2004-09-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States – name: Bethesda |
PublicationTitle | The American journal of clinical nutrition |
PublicationTitleAlternate | Am J Clin Nutr |
PublicationYear | 2004 |
Publisher | American Society for Clinical Nutrition American Society for Clinical Nutrition, Inc |
Publisher_xml | – name: American Society for Clinical Nutrition – name: American Society for Clinical Nutrition, Inc |
References | 15817875 - Am J Clin Nutr. 2005 Apr;81(4):939; aithor reply 939-40 |
References_xml | – reference: 15817875 - Am J Clin Nutr. 2005 Apr;81(4):939; aithor reply 939-40 |
SSID | ssj0012486 |
Score | 2.2807608 |
Snippet | Background: Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans.... Evidence suggests that ingesting lactic acid bacteria exerts a suppressive effect on Helicobacter pylori infection in both animals and humans. Supplementing... |
SourceID | proquest pubmed pascalfrancis fao |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 737 |
SubjectTerms | Adult Antibiosis Bacteria Bifidobacterium Bifidobacterium - physiology Bifidobacterium animalis Biological and medical sciences Breath Tests Carbon Isotopes Colony Count, Microbial diagnostic use Feeding. Feeding behavior Female Food Microbiology Fundamental and applied biological sciences. Psychology growth & development Helicobacter Infections Helicobacter Infections - microbiology Helicobacter Infections - prevention & control Helicobacter pylori Helicobacter pylori - growth & development Humans Infections lactic acid bacteria Lactobacillus Lactobacillus - physiology Lactobacillus acidophilus Lactobacillus acidophilus - physiology Male microbial load microbiology Middle Aged milk mixed culture physiology placebos prevention & control Probiotics therapeutics Treatment Outcome urease Vertebrates: anatomy and physiology, studies on body, several organs or systems viability volunteers Yogurt Yogurt - microbiology |
Title | Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori |
URI | https://www.ncbi.nlm.nih.gov/pubmed/15321816 https://www.proquest.com/docview/231939962 https://www.proquest.com/docview/49193804 https://www.proquest.com/docview/66801535 |
Volume | 80 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBAvCMZlYTD8gHiZ3KVJnCaPQIfGZRVSW2k8RbHjdJm6pGpiwfY3-MMcx85lg0rASxTZjh3lfDn-jn18DkKvYYoQibDHhLlcEI-nHgkZd4nvJoz7YyelXC0NnE79k4X36YyeDQY_e15LsmJDfv3HcyX_I1UoA7mqU7L_INm2UyiAe5AvXEHCcP0rGR93zhhqda6sXZi_qAw6LObZaiVLUm8OvMvSLFFlKjCzvCTKP11nhji8KpZyU6cJKCW7qHsz3ugr-NuvgY7CxARo0Q8frpV9n_UZ7bw7mpL341C0Ry7zJt5_t3Zv9IuMc_JN9pyCas-C2bnMyDTrlUrtFwBAXpLZeVfzVWx0T5P4O1RcFWYWbhYxvNZLq6-YganSvmLWKZ4MAN2elh3rODG_aX8dGSu-4GqGC-yhO7zVEsS3vqzBAIpekZtbUbi1WWSq7qC7DtgeKi3G5OPndmvK8er0oe0bm8CtMPaRGvmoGbdO-KR7At6SxoVyu41L-PCpTpmy3aapuc38IXpgjBL8ViPsERqIfBdZk0xU-A02kWNXeNoIchfdOzUuGY_RDwNCXKS4BSG-CUIMIMTbQYg1COFx3IAQKxDiFoS4D0KsQfgELT4cz9-fEJPOg6Sg5ysCxNz3KQ1sBnfUFwFzgECqUzA8GNmCsoCxdMRCWwBnZ07AQuamLkv5KPaZitv5FO3kRS72EBZJAqa3I0bMFZ4b85CGYZAIjydjxlMeWmgPPngUL2GijBYzR23P26E3hmEtdHBDCtFaR3WJ6kiLLvUstN-IJTJ_TRmBFRQClfcdC71qa0ERq921OBeFLCMvhCaB7W1v4ftAB6lLLfRMS7sb2wDl-daafXS_-29eoJ1qI8VLoMMVO6jh-QvXS7gk |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+ingesting+Lactobacillus-+and+Bifidobacterium-containing+yogurt+in+subjects+with+colonized+Helicobacter+pylori&rft.jtitle=The+American+journal+of+clinical+nutrition&rft.au=Wang%2C+Kuan-Yuan&rft.au=Li%2C+Shui-Nin&rft.au=Liu%2C+Chiang-Shin&rft.au=Perng%2C+Daw-Shyong&rft.date=2004-09-01&rft.issn=0002-9165&rft.volume=80&rft.issue=3&rft.spage=737&rft_id=info:doi/10.1093%2Fajcn%2F80.3.737&rft_id=info%3Apmid%2F15321816&rft.externalDocID=15321816 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9165&client=summon |